![](/img/cover-not-exists.png)
Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial
Chung, Vincent, Mansfield, Aaron S., Braiteh, Fadi, Richards, Donald, Durivage, Henry, Ungerleider, Richard S., Johnson, Francis, Kovach, John S.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-2299
Date:
December, 2016
File:
PDF, 4.65 MB
english, 2016